Significant Predictive Factors for Prognosis of Primary Upper Urinary Tract Cancer after Radical Nephroureterectomy in Taiwanese Patients

European Urology

Volumn 54, Issue 5, 2008, Pages 1127-1135

  Li, Ching Chia ^a   Chang, Tu Hao ^a   Wu, Wen Jeng ^a   Ke, Hung Lung ^a   Huang, Shu Pin ^b   Tsai, Pei Chien ^c   Chang, Shun Jen ^c   Shen, Jung Tsung ^b   Chou, Yii Her ^a   Huang, Chun Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

Author keywords

Gender; Nephroureterectomy; Outcome; Predictive factor; Recurrence; Taiwan; Transitional cell carcinoma; Upper urinary tract

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS PYELOGRAPHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROGRADE PYELOGRAPHY; RETROSPECTIVE STUDY; SEX DIFFERENCE; TAIWAN; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHROSTOMY, PERCUTANEOUS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN; TIME FACTORS; URETERAL NEOPLASMS; URETEROSTOMY; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 55649120887     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.01.054     Document Type: Article

References (30)

1. Walsh P.C., Retik A.B., Vaughan Jr. E.D., and Wein A.J. Campbell's urology. ed. 8 (2002), WB Saunders Co., Philadelphia p. 2765
2. Hafner C., Knuechel R., Stoehr R., and Hartmann A. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 101 (2002) 1-6
3. Hall M.C., Womack S., Sagalowsky A.I., Carmody T., Erickstad M.D., and Roehrborn C.G. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 52 (1998) 594-601
4. Chou Y.H., and Huang C.H. Unusual clinical presentation of upper urothelial carcinoma in Taiwan. Cancer 85 (1999) 1342-1344
5. Yang M.H., Chen K.K., Yen C.C., et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 59 (2002) 681-687
6. Rouprêt M., Traxer O., Tligui M., et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51 (2007) 709-714
7. Hatch T.R., Hefty T.R., and Barry J.M. Time-related recurrence rates in patients with upper tract transitional cell carcinoma. Urology 140 (1998) 40-41
8. Racioppi M., D'Addessi A., Alcini A., Destito A., and Alcini E. Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumors. Br J Urol 80 (1997) 707-711
9. Raman J.D., Ng C.K., Boorjian S.A., Vaughan E.D., Sosa R.E., and Scherr D.S. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. Br J Urol 96 (2005) 1031-1035
10. Muntener M., Nielsen M.E., Romero F.R., et al. Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma. Eur Urol 51 (2007) 1639-1644
11. Raman J.D., Sosa R.E., Vaughan E.D., and Scherr D.S. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology 69 (2007) 251-254
12. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 65 (2005) 279-283
13. Kang C.H., Yu T.J., Hsieh H.H., et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer 98 (2003) 1620-1626
14. Petkovic S.D. Treatment of bilateral renal pelvic and ureteral tumors: a review of 45 cases. Eur Urol 4 (1978) 397-400
15. Jiaan B.P., Yu C.C., Lee Y.H., and Huang J.K. Uraemia with concomitant urothelial cancer. Br J Urol 72 (1993) 458-461
16. Inamoto H., Ozaki R., Matsuzaki T., Wakui M., Saruta T., and Osawa A. Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients. Nephron 59 (1991) 611-617
17. Hsueh T.Y., Huang Y.H., Chiu A.W., Shen K.H., and Lee Y.H. A comparison of the clinical outcome between open and hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Br J Urol 94 (2004) 798-801
18. Holmang S., and Johansson S.L. Bilateral metachronous ureteral and renal pelvic carcinoma: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 175 (2006) 69-73
19. Huang P.C., Huang C.Y., Huang S.W., et al. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int J Urol 13 (2006) 864-869
20. Wu C.F., Chang P.L., Chen C.S., Chuang C.K., Weng H.H., and Pang S.T. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 176 (2006) 477-481
21. Wu M.J., Lian J.D., Yang C.R., et al. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan. Am J Kidney Dis 43 (2004) 1091-1097
22. Kihara K., Fukui I., Higashi Y., and Oshima H. Inhibitory effect of testosterone on gap junctional intercellular communication of human transitional cell carcinoma cell lines. Cancer Res 50 (1990) 2848-2852
23. Cozad S., Smalley S., Austenfeld M., Noble M., Jennings S., and Raymond R. Transitional cell carcinoma of the renal pelvis or ureter: patterns of failure. Urology 46 (1995) 796-800
24. Dragicevic D., Djokic M., Pekmezovic T., et al. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. Br J Urol 99 (2007) 1357-1362
25. Novara G., Marco V.D., Gottardo F., et al. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract. Cancer 110 (2007) 1715-1722
26. van der Poel H.G., Antonini N., van Tinteren H., and Horenblas S. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 48 (2005) 438-444
27. Ataus S., Onal B., Tunc B., et al. Factors affecting the survival of patients treated by standard nephroureterectomy for transitional cell carcinoma of the upper urinary tract. Int Urol and Nephrol 38 (2006) 9-13
28. Yang C.Y., Chiu H.F., Chang C.C., Ho S.C., and Wu T.N. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res 98 (2005) 127-132
29. Cosyns J.P., Jadoul M., Squifflet J.P., Wese F.X., and van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 33 (1999) 1101-1107
30. Nortier J.L., Martinez M.M., Schmeiser H.H., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342 (2000) 1686-1692